Oxybutynin Beats Placebo for Reducing ADT-Linked Hot Flashes in Prostate Cancer

TUESDAY, Feb. 10, 2026-- For men with prostate cancer experiencing androgen deprivation therapy-associated hot flashes, oxybutynin is superior to placebo in improving symptoms, according to a study published online Jan. 26 in the Journal of...